Ofatumumab
≥95%
- Product Code: 101819
CAS:
679818-59-8
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃, away from light |
Product Description:
Ofatumumab is primarily used in the treatment of chronic lymphocytic leukemia (CLL), a type of cancer that affects white blood cells. It works by targeting and binding to a specific protein on the surface of B-cells, which are often abnormal in CLL, leading to their destruction. This helps to reduce the number of cancerous cells in the body.
Additionally, ofatumumab has been approved for the treatment of relapsing forms of multiple sclerosis (MS). In this context, it helps to modulate the immune system by depleting B-cells, which are believed to play a role in the autoimmune attack on the nervous system in MS. This can reduce the frequency of relapses and slow disease progression.
The drug is administered via intravenous infusion or subcutaneous injection, depending on the condition being treated. Regular monitoring is required to manage potential side effects, such as infections, due to its impact on the immune system.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿34,870.00 |
+
-
|
Ofatumumab
Ofatumumab is primarily used in the treatment of chronic lymphocytic leukemia (CLL), a type of cancer that affects white blood cells. It works by targeting and binding to a specific protein on the surface of B-cells, which are often abnormal in CLL, leading to their destruction. This helps to reduce the number of cancerous cells in the body.
Additionally, ofatumumab has been approved for the treatment of relapsing forms of multiple sclerosis (MS). In this context, it helps to modulate the immune system by depleting B-cells, which are believed to play a role in the autoimmune attack on the nervous system in MS. This can reduce the frequency of relapses and slow disease progression.
The drug is administered via intravenous infusion or subcutaneous injection, depending on the condition being treated. Regular monitoring is required to manage potential side effects, such as infections, due to its impact on the immune system.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :